On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: NYC Enforcement Blitz, CA Surveillance Pricing, and PA Criminal History Rule Update - Employment Law This Week
- EEOC Sends Warning to Fortune 500: What Employers Should Know
- Harassment Prevention in 2026
- NYC Employers: Are You Ready for a Protected Time Off Law (ESSTA) Enforcement Blitz?
- AI Hiring Tools and Consumer Reports: Understanding the Eightfold Litigation